Article Details
Retrieved on: 2024-08-19 17:32:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On Monday, Oppenheimer maintained its Outperform rating and $200.00 price target for TransMedics Group (NASDAQ:TMDX), a medical technology company ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here